Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Investing.com -- Galapagos stock fell 15% after the biotechnology company announced it would wind down its cell therapy business following unsuccessful attempts to find a buyer for the unit. The ...

Let network strength, affordability and features lead you to the best cell phone plan for your needs. Many, or all, of the products featured on this page are from our advertising partners who ...

A novel technology that utilizes light of different wavelengths to control cellular functions by inducing reversible assembly and disassembly of molecules has been developed. This breakthrough could ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Galapagos NV is winding down its cell and gene therapy (CGT) division after an unsuccessful attempt to sell the unit, becoming the latest biotech to retreat from a sector that has lost momentum after ...

Things are not going well for the Iowa State Cyclones football team heading into their Week 8 bye. After starting the season 5-0 and being ranked as high as No. 12, they are now riding a two-game ...

Investors looked past a 22% drop in CSX’s third quarter earnings Thursday and focused on the direction the railroad’s new CEO might take it and the possibility of any strategic deals. CEO Steve Angel ...

Four killed, eleven injured after speeding driver plows into Ybor City crowd A high-speed chase in Tampa ended early Saturday when a 22-year-old driver slammed into a Ybor City crowd, killing four and ...

Update Oct. 20, 1:15 p.m. UTC: This article has been updated to include comments from Dr. Max Li, founder and CEO of OORT. Coinbase and Robinhood were among several major platforms distressed by an ...